Medical/Pharmaceuticals

Glucagon Receptor Structures Reveal G protein Specificity Mechanism

SHANGHAI, March 19, 2020 /PRNewswire/ -- Recently, scientists at Shanghai Institute ofMateria Medica (SIMM) of Chinese Academy of Sciences, together with scientists at Institute of Biophysics (IBP) of Chinese Academy of Sciences and Monash University, determined two cryo-electron microscopy (cryo...

2020-03-20 02:00 2018

Atomo Diagnostics Issues Supplementary IPO Prospectus in Response to Multiple COVID-19 Rapid Blood Test Requests

SYDNEY, March 19, 2020 /PRNewswire/ -- Australian rapid blood test company Atomo Diagnostics Limited said today it was working with potential original equipment manufacturing customers to develop rapid self-tests for COVID-19 that could deliver results in as little as 15 minutes, and be deployed ...

2020-03-19 16:43 2438

Glooko Enables Remote Patient Care at No Charge to Medical Clinics and People with Diabetes to Minimize Risk During Pandemic

STATEMENT FROM GLOOKO RE: COVID-19 SERVICE MOUNTAIN VIEW, California, March 19, 2020 /PRNewswire/ -- Throughout this challenging time of the COVID-19 pandemic, Glooko, a leading diabetes software company that enables people with diabetes and clinicians to manage care in real-time, is committed t...

2020-03-19 11:18 1485

Getinge Increases Production Capacity of Ventilators with 60% to Support the Needs of Global Intensive Care Units

GOTHENBURG, Sweden, March 18, 2020 /PRNewswire/ -- Getinge has since the outbreak of the COVID-19 pandemic seen an increased global demand for ventilators, extra corporeal life support (ECLS) equipment and advanced monitoring for Intensive Care Units. To meet the global demand Getinge will tempo...

2020-03-18 01:32 6508

Vakrangee Revolutionizes Rural Healthcare by Introducing vHealth By Aetna's (a CVS Health Company) Telemedicine Services at Vakrangee Nextgen Kendras

MUMBAI, India, March 17, 2020 /PRNewswire/ -- Vakrangee Limited introduces vHealth by Aetna primary care services through its network of Vakrangee Kendras. vHealth is a fully owned subsidiary of Aetna Inc, a CVS Health Company, one of the world's leading health services providers (Fortune 8 Ente...

2020-03-17 23:42 3149

ChemPartner Introduces New State-of-the-Art Global Operation Center in Shanghai

SHANGHAI, March 17, 2020 /PRNewswire/ -- Shanghai ChemPartner announced the opening of a new, state-of-the-art,24,000 m2 laboratory facility in the Zhangjiang Hi-Tech Park inShanghai, China. The building, operating as ChemPartner's new Global Operation Center, houses approximately 700 employees ...

2020-03-17 23:07 1897

Happiness Biotech Begun Production of Daily Protective Masks

NANPING, China, March 17, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that the Company has begun production of daily protective masks. Due to the shortage of melt-bl...

2020-03-17 20:00 6232

HeiQ Viroblock NPJ03 Antiviral Textile Technology Tested Effective Against Coronavirus

ZURICH, March 17, 2020 /PRNewswire/ -- HeiQ , winner of the Swiss Technology Award and Swiss Environmental Award, launches HeiQ Viroblock NPJ03, an antiviral and antimicrobial textile treatment tested effective against coronavirus.

2020-03-17 16:00 3983

Beauty Tourism is Causing A Rising Need For Surgical Revisions

SINGAPORE, March 17, 2020 /PRNewswire/ -- Dr. Ivan Puah, Medical Director of Amaris B. Clinic, has noticed a rise in failed results, such as botched procedures in liposuction and gynecomastia surgery, among patients who had their cosmetic procedures done overseas. Dr. Puah, accredited by the M...

2020-03-17 09:30 3005

InxMed Announces Dosing of First Patient in a Phase Ib Trial of IN10018 as Monotherapy and Combination Therapy in Patients with Uveal Melanoma and NRAS mutant Metastatic Melanoma in the United States

SHANGHAI, March 17, 2020 /PRNewswire/ -- InxMed (Shanghai) Co., Ltd. ("InxMed" or "Company"), a clinical stage biotech company dedicated to developing innovative, individualized medicines with international impact, announced today that the company has dosed first patient in its Phase Ib clinical ...

2020-03-17 09:05 2991

Samsung Biologics expands presence in Greater China Region with CDO partnership for Alzheimer's candidate

SONGDO, South Korea, March 16, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) entered into a contract development and manufacturing agreement with APRINOIA Therapeutics to develop an anti-tau monoclonal antibody candidate to treat primary and secondary tauopathies, including Progressive Supr...

2020-03-17 08:04 1451

Covid-19: Menarini Group Converts Production Plant to Produce and Donate Disinfectant Gel

FLORENCE, Italy, March 17, 2020 /PRNewswire/ -- United in the fight against  Covid-19. In a difficult time for Italy and the entire world, pharmaceutical company Menarini Group is taking healthcare professionals and patient health even more to heart. The Board of Directors of Menarini, chaired by...

2020-03-17 05:16 2713

EnGeneIC Announces Publication in Cancer Cell of a Scientific Paper Highlighting the Ability of EDV™ Nanocells to Mount Dual Assault on Cancer Cells

EDV™ Technology Stimulates Both Innate and Adaptive Immune Response and Confers Long-Term Survival Research Paves Way for Treatment of Drug-Resistant, End-Stage Cancers NEW YORK and SYDNEY, March 17, 2020 /PRNewswire/ -- EnGeneIC Limited, a clinical-stage biopharmaceutical company advancing its ...

2020-03-17 00:35 2039

China SXT Pharmaceuticals, Inc. Announces That It Received a Grant Supported by City Government

TAIZHOU, China, March 16, 2020 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC ) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales o...

2020-03-16 21:16 5064

Mentice Expands Coronary Product Portfolio with the Introduction of Coronary Intermediate Software

STOCKHOLM, March 16, 2020 /PRNewswire/ -- Mentice AB (STO: MNTC), a world leader in simulation solutions for endovascular therapies, introduces Coronary Intermediate as the latest software addition to the Coronary Product Portfolio. Coronary Intermediate follows the introduction of Coronary Essen...

2020-03-16 18:34 2343

Fosun Joins Hands with Benevolent Enterprises in Urgent Donation of 45,500 Medical Protection Supplies Items to Italy

HONG KONG, March 16, 2020 /PRNewswire/ -- On March 14, at 23:50 (Beijing Time), 16:50 in the afternoon (Milan Time), the first batch of medical protection supplies from "Global Anti-virus Relief Scheme" launched by Fosun as well as the second batch donated by Fosun toItaly which consists of 45,50...

2020-03-16 10:27 4372

Yuyu Pharma, Medicine Donation to Korean Red Cross

SEOUL, South Korea, March 16, 2020 /PRNewswire/ -- Yuyu Pharma (CEO Robert Wonsang Yu) (KRX 000220) has donated vitamins, anti-fever medicine, and anti-allergy medication to help the people in Daegu and Gyeongbuk regions, which have both been hit hard by the Coronavirus. These include the vitamin...

2020-03-16 08:00 2953

CPHI to Hold Fiscal Year 2019 Earnings Conference Call On Tuesday March 31, 2020 at 8:30 a.m. ET

HAIKOU CITY, China, March 13, 2020 /PRNewswire/ -- China Pharmaceutical Holdings Limited (NYSE American: CPHI) ("China Pharma" or "Company"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that it plans to hold its f...

2020-03-13 20:30 6229

Merck and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study

Not intended for US-, Canada- and UK-based media  DARMSTADT, Germany and NEW YORK, March 13, 2020 /PRNewswire/ -- Merck and Pfizer Inc. (NYSE: PFE) today announced an update from the Phase III JAVELIN Head and Neck 100 study evaluating avelumab in addition to chemoradiotherapy (CRT) versus stand...

2020-03-13 20:00 8070

Embracing the Age of Innovation with Chinese Pharmaceutical Practitioners, CPhI China Returns with its 20th Edition in 2020

SHANGHAI, March 13, 2020 /PRNewswire/ -- China's pharmaceutical industry is rapidly switching from the "quantity increase" to the "quality improvement", developing from a "generic drug power" to an "innovative drug power". CPhI China, a participant and witness of this historic stage, has forged a...

2020-03-13 09:00 3488
1 ... 587588589590591592593 ... 610

Week's Top Stories